tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

QURE Stock Latest News

uniQure appoints Kylie O’Keefe as chief customer, strategy officer
The FlyuniQure appoints Kylie O’Keefe as chief customer, strategy officer
14h ago
QURE
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
PremiumThe Fly
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
9d ago
CLPT
QURE
Positive Outlook for uniQure’s AMT-130 Program Drives Buy Rating Amid Regulatory Advancements and Robust Clinical Framework
PremiumRatings
Positive Outlook for uniQure’s AMT-130 Program Drives Buy Rating Amid Regulatory Advancements and Robust Clinical Framework
9d ago
QURE
Buy Rating for uniQure Driven by Promising AMT-130 Advancements and Strategic FDA Alignment
PremiumRatings
Buy Rating for uniQure Driven by Promising AMT-130 Advancements and Strategic FDA Alignment
9d ago
QURE
RBC Capital views FDA flexibility on another HD drug as positive for PTC’s ‘518
PremiumThe Fly
RBC Capital views FDA flexibility on another HD drug as positive for PTC’s ‘518
9d ago
PTCT
QURE
uniQure’s AMT-130 Gains Momentum with FDA Support and Promising Clinical Outlook
PremiumRatingsuniQure’s AMT-130 Gains Momentum with FDA Support and Promising Clinical Outlook
10d ago
QURE
uniQure Aligns with FDA for AMT-130 BLA Approval
Premium
Company Announcements
uniQure Aligns with FDA for AMT-130 BLA Approval
10d ago
8K
QURE
uniQure provides regulatory update on AMT-130 for Huntington’s Disease
Premium
The Fly
uniQure provides regulatory update on AMT-130 for Huntington’s Disease
10d ago
QURE
Buy Recommendation for uniQure Driven by Promising AMT-260 Trial Results and Innovative LinQURE Technology
PremiumRatings
Buy Recommendation for uniQure Driven by Promising AMT-260 Trial Results and Innovative LinQURE Technology
13d ago
QURE
Promising Early Data and Strategic Expansion Bolster Buy Rating for uniQure’s AMT-260 Program
PremiumRatings
Promising Early Data and Strategic Expansion Bolster Buy Rating for uniQure’s AMT-260 Program
13d ago
QURE
uniQure early AMT-260 data encouraging, says H.C. Wainwright
PremiumThe Fly
uniQure early AMT-260 data encouraging, says H.C. Wainwright
13d ago
QURE
uniQure presents case study of first patient dosed with AMT-260
PremiumThe Fly
uniQure presents case study of first patient dosed with AMT-260
14d ago
QURE
Unusually active option classes on open May 21st
PremiumThe FlyUnusually active option classes on open May 21st
22d ago
BTU
TGT
uniQure’s Clinical and Regulatory Progress Drives Buy Rating Amid Market Overreaction
Premium
Ratings
uniQure’s Clinical and Regulatory Progress Drives Buy Rating Amid Market Overreaction
29d ago
QURE
Optimistic Buy Rating on uniQure Amidst Progress in Huntington’s Disease Program and AMT-130 Developments
Premium
Ratings
Optimistic Buy Rating on uniQure Amidst Progress in Huntington’s Disease Program and AMT-130 Developments
30d ago
QURE
uniQure N.V. Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
uniQure N.V. Earnings Call: Progress Amid Challenges
1M ago
QURE
uniQure Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
uniQure Reports Q1 2025 Progress and Financials
1M ago
QURE
Optimistic Outlook on uniQure’s AMT-130 Program Amidst Regulatory Progress and Market Volatility
PremiumRatings
Optimistic Outlook on uniQure’s AMT-130 Program Amidst Regulatory Progress and Market Volatility
1M ago
QURE
uniQure’s Promising Developments and Regulatory Progress Drive Buy Rating
PremiumRatings
uniQure’s Promising Developments and Regulatory Progress Drive Buy Rating
1M ago
QURE
Morning Movers: Pinterest, Lyft jump following quarterly results
PremiumThe FlyMorning Movers: Pinterest, Lyft jump following quarterly results
1M ago
TU
AGM
uniQure reports Q1 EPS (82c), consensus (93c)
Premium
The Fly
uniQure reports Q1 EPS (82c), consensus (93c)
1M ago
QURE
uniQure expects cash to fund operations into 2H of 2027
Premium
The Fly
uniQure expects cash to fund operations into 2H of 2027
1M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >